Trius Therapeutics Inc (TSRX) Annual Balance Sheets

Annual · GAAP · USD millions
Access TSRX quarterly Balance Sheets →
The table below presents a historical view of Trius Therapeutics Inc's balance sheet, supporting analysis of financial position trends.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2012)
(Dec 31 2011)
Assets
Cash & cash equivalent16.37
Restricted Cash and Cash Equivalents, Current0.15
Available-for-sale Securities, Current MA49.66
Cash & Short-term Investments65.00
Accounts receivable5.70
Prepaid Expense And Other Assets Current2.25
Total Current Assets74.13
Equipment/Property/Plant Net0.99
Other Assets, Noncurrent0.15
Total Assets75.27
Liabilities
Accounts Payable, Current AC6.76
Accrued Liabilities, Current AC7.76
Deferred Revenue, Current DE0.12
Total Current Liabilities18.49
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Common Stock Warrants Liability Current3.85
Total Liabilities18.49
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock206.09
Retained Earnings / Accumulated Deficit-149.32
Other Equity0.01
Common Stockholder's Equity56.79
Total Stockholder's Equity56.79
Liabilities & Stockholder's Equity75.27
4 historic quarters locked

Sign in to unlock the full Trius Therapeutics Inc balance sheet history.

About TSRX Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License